Search

Your search keyword '"De Bree, Remco"' showing total 411 results

Search Constraints

Start Over You searched for: Author "De Bree, Remco" Remove constraint Author: "De Bree, Remco" Database Unpaywall Remove constraint Database: Unpaywall
411 results on '"De Bree, Remco"'

Search Results

2. Improved delineation with diffusion weighted imaging for laryngeal and hypopharyngeal tumors validated with pathology

3. Feasibility of an MR-based digital specimen for tongue cancer resection specimens: a novel approach for margin evaluation

5. The Additional Value of Somatostatin Receptor Positron Emission Computed Tomography ([68Ga]Ga-DOTATOC PET/CT) Compared with Magnetic Resonance Imaging of the Head and Neck Region in Paraganglioma Patients: A Pilot Study

7. The development of a decision aid for patients with operable oropharyngeal carcinoma in the Netherlands – A mixed methods study

9. Improved Delineation with Diffusion Weighted Imaging for Laryngeal and Hypopharyngeal Tumors Validated with Pathology

11. Validation of the “Rome” Classification for Squamous Cell Carcinoma of the Nasal Vestibule

12. Low dose cisplatin weekly versus high dose cisplatin every three weeks in primary chemoradiotherapy in head and neck cancer patients with low skeletal muscle mass: The CISLOW-study protocol

13. Dual targeting of cancer metabolome and stress antigens affects transcriptomic heterogeneity and efficacy of engineered T cells

18. Lymph Node Metastases from Non-Melanoma Skin Cancer of the Head and Neck

19. Survival Outcomes in T3 Laryngeal Cancers: Primary Total Laryngectomy vs. Concurrent Chemoradiation or Radiation Therapy—A Meta-Analysis

21. Author Correction: Accurate detection of circulating tumor DNA using nanopore consensus sequencing

23. Patient-derived head and neck cancer organoids allow treatment stratification and serve as a tool for biomarker validation and identification

24. Data from Oral Mucosal Organoids as a Potential Platform for Personalized Cancer Therapy

25. Movie S1 from Oral Mucosal Organoids as a Potential Platform for Personalized Cancer Therapy

26. Movie S3 from Oral Mucosal Organoids as a Potential Platform for Personalized Cancer Therapy

27. Movie S5 from Oral Mucosal Organoids as a Potential Platform for Personalized Cancer Therapy

28. Movie S4 from Oral Mucosal Organoids as a Potential Platform for Personalized Cancer Therapy

29. Movie S2 from Oral Mucosal Organoids as a Potential Platform for Personalized Cancer Therapy

30. Supplementary Data from Oral Mucosal Organoids as a Potential Platform for Personalized Cancer Therapy

31. Supplementary Data from Oral Mucosal Organoids as a Potential Platform for Personalized Cancer Therapy

32. Movie S2 from Oral Mucosal Organoids as a Potential Platform for Personalized Cancer Therapy

33. Supplementary Data from Oral Mucosal Organoids as a Potential Platform for Personalized Cancer Therapy

34. Movie S1 from Oral Mucosal Organoids as a Potential Platform for Personalized Cancer Therapy

35. Movie S3 from Oral Mucosal Organoids as a Potential Platform for Personalized Cancer Therapy

36. Supplementary Data from Oral Mucosal Organoids as a Potential Platform for Personalized Cancer Therapy

37. Movie S4 from Oral Mucosal Organoids as a Potential Platform for Personalized Cancer Therapy

38. Supplementary Data from Oral Mucosal Organoids as a Potential Platform for Personalized Cancer Therapy

39. Movie S5 from Oral Mucosal Organoids as a Potential Platform for Personalized Cancer Therapy

40. Data from Oral Mucosal Organoids as a Potential Platform for Personalized Cancer Therapy

41. Supplementary Data from Oral Mucosal Organoids as a Potential Platform for Personalized Cancer Therapy

42. Cohort profile of PLUTO: a perioperative biobank focusing on prediction and early diagnosis of postoperative complications

44. Supplementary Table S2 from Improved Recurrence-Free Survival with ARCON for Anemic Patients with Laryngeal Cancer

45. Supplementary Figure S1. FGFR1 protein expression and FGFR1 gene copy-numbers in HPV-positive and HPV-negative head and neck squamous cell carcinoma. from FGFR1 Is a Potential Prognostic Biomarker and Therapeutic Target in Head and Neck Squamous Cell Carcinoma

46. Supplementary Table S2 from Improved Recurrence-Free Survival with ARCON for Anemic Patients with Laryngeal Cancer

47. Supplementary Table S1. Results of FGFR1 protein expression and FGFR1 gene copy-numbers in HPV-positive and HPV-negative head and neck squamous cell carcinoma. from FGFR1 Is a Potential Prognostic Biomarker and Therapeutic Target in Head and Neck Squamous Cell Carcinoma

48. Supplementary Table S3 from Improved Recurrence-Free Survival with ARCON for Anemic Patients with Laryngeal Cancer

49. Supplementary Table S1 from Improved Recurrence-Free Survival with ARCON for Anemic Patients with Laryngeal Cancer

50. Supplementary Table S1 from Improved Recurrence-Free Survival with ARCON for Anemic Patients with Laryngeal Cancer

Catalog

Books, media, physical & digital resources